Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkin-Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06292741
What this trial is testing

Autonomic Involvement in Patient With Cognitive Decline

Who this might be right for
Dementia, MildDementia of Alzheimer Type
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 120
Early research (Phase 1)Ended earlyNCT06028373
What this trial is testing

ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas

Who this might be right for
Advanced Solid TumorsB-cell Non-Hodgkin Lymphomas
Antengene Biologics Limited 38
Early research (Phase 1)Ended earlyNCT01769222
What this trial is testing

Ipilimumab and Local Radiation for Selected Solid Tumors

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Stanford University 3
Testing effectiveness (Phase 2)Looking for participantsNCT07283822
What this trial is testing

Amping up With PemJAK

Who this might be right for
Non-Hodgkin LymphomaHodgkin Disease LymphomaNon-Hodgkin Lymphoma Refractory/ Relapsed+5 more
Seda S. Tolu 53
Testing effectiveness (Phase 2)Study completedNCT00875056
What this trial is testing

Study of Vorinostat (MK-0683) With Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL), or Mantle Cell Lymphoma (MCL) Participants (MK-0683-103)

Who this might be right for
Lymphoma
Merck Sharp & Dohme LLC 56
Testing effectiveness (Phase 2)Study completedNCT00002657
What this trial is testing

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
SWOG Cancer Research Network 20
Testing effectiveness (Phase 2)UnknownNCT05059912
What this trial is testing

CD7 CAR T-cell for R/R CD7+ T Cell Lymphoma

Who this might be right for
Refractory and Relapsed T Cell Lymphoma
The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Study completedNCT05064319
What this trial is testing

Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders

Who this might be right for
Bipolar DisorderCannabis UseSchizoaffective Disorder, Bipolar Type+5 more
Medical University of South Carolina 51
Early research (Phase 1)WithdrawnNCT05867030
What this trial is testing

Parsaclisib in Patients With Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Innovent Biologics (Suzhou) Co. Ltd.
Early research (Phase 1)Looking for participantsNCT06732492
What this trial is testing

RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies

Who this might be right for
NK T-Cell LymphomaCART TherapyCD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10
Large-scale testing (Phase 3)Study completedNCT00052936
What this trial is testing

Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
German High-Grade Non-Hodgkin's Lymphoma Study Group 1,506
Very early researchLooking for participantsNCT06636175
What this trial is testing

64Cu-LLP2A for Imaging Hematologic Malignancies

Who this might be right for
Multiple MyelomaLow-Grade LymphomaFollicular Lymphoma+4 more
Washington University School of Medicine 42
Early research (Phase 1)Ended earlyNCT03601819
What this trial is testing

Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders

Who this might be right for
Lymphoma, T-Cell, CutaneousLymphoma, T-Cell, PeripheralChronic Lymphocytic Leukemia+4 more
University of Michigan Rogel Cancer Center 4
Large-scale testing (Phase 3)Study completedNCT03595800
What this trial is testing

Extension of a Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor to Younger Patients Eligible for Reduced-intensity Conditioning Regimen

Who this might be right for
Acute LeukemiaNon Hodgkin LymphomaMultiple Myeloma
Institut Paoli-Calmettes 9
Testing effectiveness (Phase 2)Looking for participantsNCT04544592
What this trial is testing

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaB-cell Non Hodgkin Lymphoma
University of Colorado, Denver 45
Very early researchUnknownNCT05979792
What this trial is testing

Clinical Study of CD7 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory CD7-positive Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Zhao Weili 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07457177
What this trial is testing

Phaes Ⅱ Study of Golidocitinib-Pegaspargase-PD-1 Antibody First-Line for Advanced ENKTL

Who this might be right for
NK T-Cell Lymphoma
LIANG WANG 40
Testing effectiveness (Phase 2)Study completedNCT00477412
What this trial is testing

Bortezomib, Rituximab and Combination Chemotherapy in Treating Participants With Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
M.D. Anderson Cancer Center 107
Not applicableStudy completedNCT02708732
What this trial is testing

Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-Cell Lymphoma
Hoffmann-La Roche 91
Testing effectiveness (Phase 2)Study completedNCT00732498
What this trial is testing

Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL

Who this might be right for
Lymphoma
University of Arizona 28
Next Page